151 related articles for article (PubMed ID: 30008697)
1. XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the
Adamik J; Silbermann R; Marino S; Sun Q; Anderson JL; Zhou D; Xie XQ; Roodman GD; Galson DL
Front Endocrinol (Lausanne); 2018; 9():344. PubMed ID: 30008697
[TBL] [Abstract][Full Text] [Related]
2. EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast Differentiation.
Adamik J; Jin S; Sun Q; Zhang P; Weiss KR; Anderson JL; Silbermann R; Roodman GD; Galson DL
Mol Cancer Res; 2017 Apr; 15(4):405-417. PubMed ID: 28119431
[TBL] [Abstract][Full Text] [Related]
3. Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo.
Teramachi J; Silbermann R; Yang P; Zhao W; Mohammad KS; Guo J; Anderson JL; Zhou D; Feng R; Myint KZ; Maertz N; Beumer JH; Eiseman JL; Windle JJ; Xie XQ; Roodman GD; Kurihara N
Leukemia; 2016 Feb; 30(2):390-8. PubMed ID: 26286116
[TBL] [Abstract][Full Text] [Related]
4. Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease.
D'Souza S; del Prete D; Jin S; Sun Q; Huston AJ; Kostov FE; Sammut B; Hong CS; Anderson JL; Patrene KD; Yu S; Velu CS; Xiao G; Grimes HL; Roodman GD; Galson DL
Blood; 2011 Dec; 118(26):6871-80. PubMed ID: 22042697
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Signatures at the RUNX2-P1 and Sp7 Gene Promoters Control Osteogenic Lineage Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells.
Sepulveda H; Aguilar R; Prieto CP; Bustos F; Aedo S; Lattus J; van Zundert B; Palma V; Montecino M
J Cell Physiol; 2017 Sep; 232(9):2519-2527. PubMed ID: 27689934
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma.
Marino S; Petrusca DN; Bishop RT; Anderson JL; Sabol HM; Ashby C; Layer JH; Cesarano A; Davé UP; Perna F; Delgado-Calle J; Chirgwin JM; Roodman GD
Haematologica; 2024 May; 109(5):1501-1513. PubMed ID: 37981834
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner.
Hu X; Zhang X; Dai L; Zhu J; Jia Z; Wang W; Zhou C; Ao Y
Stem Cells Dev; 2013 Jan; 22(2):248-55. PubMed ID: 22873791
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Runx2 signaling by TNF-α in ST2 murine bone marrow stromal cells undergoing osteogenic differentiation.
Ye X; Huang H; Zhao N; Zhang J; Yang P
In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):1026-1033. PubMed ID: 27401008
[TBL] [Abstract][Full Text] [Related]
10. Polycomb PRC2 complex mediates epigenetic silencing of a critical osteogenic master regulator in the hippocampus.
Aguilar R; Bustos FJ; Saez M; Rojas A; Allende ML; van Wijnen AJ; van Zundert B; Montecino M
Biochim Biophys Acta; 2016 Aug; 1859(8):1043-55. PubMed ID: 27216774
[TBL] [Abstract][Full Text] [Related]
11. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1.
Duan Z; Zarebski A; Montoya-Durango D; Grimes HL; Horwitz M
Mol Cell Biol; 2005 Dec; 25(23):10338-51. PubMed ID: 16287849
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of osteogenic differentiation of human adipose-derived stromal cells by retinoblastoma binding protein 2 repression of RUNX2-activated transcription.
Ge W; Shi L; Zhou Y; Liu Y; Ma GE; Jiang Y; Xu Y; Zhang X; Feng H
Stem Cells; 2011 Jul; 29(7):1112-25. PubMed ID: 21604327
[TBL] [Abstract][Full Text] [Related]
13. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene.
Hassan MQ; Javed A; Morasso MI; Karlin J; Montecino M; van Wijnen AJ; Stein GS; Stein JL; Lian JB
Mol Cell Biol; 2004 Oct; 24(20):9248-61. PubMed ID: 15456894
[TBL] [Abstract][Full Text] [Related]
14. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29a ameliorates glucocorticoid-induced suppression of osteoblast differentiation by regulating β-catenin acetylation.
Ko JY; Chuang PC; Chen MW; Ke HC; Wu SL; Chang YH; Chen YS; Wang FS
Bone; 2013 Dec; 57(2):468-75. PubMed ID: 24096265
[TBL] [Abstract][Full Text] [Related]
16. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose--derived stem cells in vitro and in vivo.
Zhang X; Yang M; Lin L; Chen P; Ma KT; Zhou CY; Ao YF
Calcif Tissue Int; 2006 Sep; 79(3):169-78. PubMed ID: 16969589
[TBL] [Abstract][Full Text] [Related]
17. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
18. Osteogenic differentiation of C2C12 myogenic progenitor cells requires the Fos-related antigen Fra-1 - a novel target of Runx2.
Yu S; Geng Q; Sun F; Yu Y; Pan Q; Hong A
Biochem Biophys Res Commun; 2013 Jan; 430(1):173-8. PubMed ID: 23159633
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic-Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease.
Adamik J; Roodman GD; Galson DL
JBMR Plus; 2019 Mar; 3(3):e10183. PubMed ID: 30918921
[TBL] [Abstract][Full Text] [Related]
20. microRNA-103a functions as a mechanosensitive microRNA to inhibit bone formation through targeting Runx2.
Zuo B; Zhu J; Li J; Wang C; Zhao X; Cai G; Li Z; Peng J; Wang P; Shen C; Huang Y; Xu J; Zhang X; Chen X
J Bone Miner Res; 2015 Feb; 30(2):330-45. PubMed ID: 25195535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
